|
| 38048985 | Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained. | Value Health | 2024 |
| 34666861 | Length of Stay and Home Discharge for Patients with Inpatient Stroke Rehabilitation. | Can J Neurol Sci | 2023 |
| 34520280 | Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada. | Can J Psychiatry | 2022 |
| 37881305 | Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP): Protocol for a multicentre cluster randomised trial comparing a complex intervention for medication optimization against usual care. | NIHR Open Res | 2022 |
| 35470347 | Examination of Care Milestones for Preventing Congenital Syphilis Transmission Among Syphilis-Infected Pregnant Women in Alberta, Canada: 2017-2019. | Sex Transm Dis | 2022 |
| 35779939 | A Conceptual Framework for Life-Cycle Health Technology Assessment. | Value Health | 2022 |
| 35264163 | An observational cohort study of health outcomes and costs associated with early pregnancy assessment units in the UK. | BMC Health Serv Res | 2022 |
| 33411824 | Nobody ever questions-Polypharmacy in care homes: A mixed methods evaluation of a multidisciplinary medicines optimisation initiative. | PLoS One | 2021 |
| 34847201 | Differences in the organisation of early pregnancy units and the effect of senior clinician presence, volume of patients and weekend opening on emergency hospital admissions: Findings from the VESPA Study. | PLoS One | 2021 |
| 34649534 | Interpersonal counselling versus perinatal-specific cognitive behavioural therapy for women with depression during pregnancy offered in routine psychological treatment services: a phase II randomised trial. | BMC Psychiatry | 2021 |
| 34103058 | Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada. | Harm Reduct J | 2021 |
| 34138458 | A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine. | Pharmacoeconomics | 2021 |
| 34048692 | ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. | Stem Cell Reports | 2021 |
| 33217588 | Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, Alberta. | Ann Hepatol | 2021 |
| 32576158 | Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. | BMC Public Health | 2020 |
| 31104733 | Caring for Carers: Positive and Normative Challenges for Future Research on Carer Spillover Effects in Economic Evaluation. | Value Health | 2019 |
| 31427346 | Protocol for a feasibility randomised trial of low-intensity interventions for antenatal depression: ADAGIO trial comparing interpersonal counselling with cognitive behavioural therapy. | BMJ Open | 2019 |
| 31509537 | Nurse-led medicines' monitoring in care homes, implementing the Adverse Drug Reaction (ADRe) Profile improvement initiative for mental health medicines: An observational and interview study. | PLoS One | 2019 |
| 31505957 | Hard choices: Reflections from the tomb of the unknown patient. | Healthc Manage Forum | 2019 |
| 31275578 | Clinical and cost-effectiveness of the Ross procedure versus conventional aortic valve replacement in young adults. | Open Heart | 2019 |
| 28573333 | Incorporating equity in economic evaluations: a multi-attribute equity state approach. | Eur J Health Econ | 2018 |
| 30269073 | Nurse-led medicines' monitoring in care homes study protocol: a process evaluation of the impact and sustainability of the adverse drug reaction (ADRe) profile for mental health medicines. | BMJ Open | 2018 |
| 30468145 | Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. | Health Technol Assess | 2018 |
| 30381374 | Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). | BMJ | 2018 |
| 29498001 | Once Bitten Twice Shy: Thinking Carefully Before Adopting the EQ-5D-5L. | Pharmacoeconomics | 2018 |
| 28987452 | Lancet Commission: Stem cells and regenerative medicine. | Lancet | 2018 |
| 29150405 | Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England. | Lancet Gastroenterol Hepatol | 2018 |
| 28733300 | Exploring the relationship between frequent internet use and health and social care resource use in a community-based cohort of older adults: an observational study in primary care. | BMJ Open | 2017 |
| 28340553 | Promoting independence, health and well-being for older people: a feasibility study of computer-aided health and social risk appraisal system in primary care. | BMC Fam Pract | 2017 |
| 28298226 | Addressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan. | Global Health | 2017 |
| 29441504 | Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. | Pharmacoecon Open | 2017 |
| 27601503 | Total ankle replacement versus arthrodesis (TARVA): protocol for a multicentre randomised controlled trial. | BMJ Open | 2016 |
| 24644163 | Evaluating a complex system-wide intervention using the difference in differences method: the Delivering Choice Programme. | BMJ Support Palliat Care | 2015 |
| 26614627 | Randomised, single-masked non-inferiority trial of femtosecond laser-assisted versus manual phacoemulsification cataract surgery for adults with visually significant cataract: the FACT trial protocol. | BMJ Open | 2015 |
| 26199134 | Estimating the cost of caring for people with cancer at the end of life: A modelling study. | Palliat Med | 2015 |
| 25595871 | An educational review of the statistical issues in analysing utility data for cost-utility analysis. | Pharmacoeconomics | 2015 |
| 23975376 | A framework for understanding quality of life in individuals without capacity. | Qual Life Res | 2014 |
| 25407558 | A cost-utility analysis of a rehabilitation service for people living with and beyond cancer. | BMC Health Serv Res | 2014 |
| 25061120 | Behavioural and psychiatric symptoms in people with dementia admitted to the acute hospital: prospective cohort study. | Br J Psychiatry | 2014 |
| 24273127 | An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. | Sex Transm Infect | 2014 |
| 23182307 | Rehabilitation in advanced, progressive, recurrent cancer: a randomized controlled trial. | J Pain Symptom Manage | 2013 |
| 23393040 | Understanding Harris' understanding of CEA: is cost effective resource allocation undone? | J Health Serv Res Policy | 2013 |
| 22122273 | Urinary tract infections in children and the risk of ESRF. | Acta Paediatr | 2012 |
| 23187973 | CoMPASs: IOn programme (Care Of Memory Problems in Advanced Stages of dementia: Improving Our Knowledge): protocol for a mixed methods study. | BMJ Open | 2012 |
| 22591713 | Is a QALY still a QALY at the end of life? | J Health Econ | 2012 |
| 22337355 | Death, time, and the theory of relativity: a brief reply? | J Pain Symptom Manage | 2012 |
| 20809381 | Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease. | Diabetologia | 2011 |
| 21291629 | A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease. | Health Technol Assess | 2011 |
| 21504241 | Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence. | Pharmacoeconomics | 2011 |
| 20190294 | Gestational diabetes mellitus: NICE for the U.S.? A comparison of the American Diabetes Association and the American College of Obstetricians and Gynecologists Guidelines With the U.K. National Institute for Health and clinical excellence guidelines: response to Simmons et al. | Diabetes Care | 2010 |